Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB01609
http://purl.obolibrary.org/obo/dinto_DB01609
|
|---|---|
| Preferred Name | deferasirox |
| Synonyms |
C21H15N3O4
4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | deferasirox
|
|---|---|
| label | deferasirox
|
| chelates | |
| DBSynonym |
deferasiroxum [inn-latin]
icl 670
|
| ATCCode | V03AC03
|
| Definition | Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long term blood transfusions for conditions such as beta-thalassemia and other chronic anemias. It is the first oral medication approved in the USA for this purpose.
|
| has effect |
See more
See less
|
| has pharmacological target | |
| induces | |
| type | |
| InChIKey | InChIKey=BOFQWVMAQOTZIW-UHFFFAOYSA-N
|
| Synonym |
C21H15N3O4
4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
|
| xref |
Drugs Product Database (DPD):1926756
National Drug Code Directory:0078-0468-15
PharmGKB:PA164760843
PubChem Substance:46506791
Drugs.com:http://www.drugs.com/cdi/deferasirox.html
PubChem Compound:5493381
ChemSpider:4591431
Wikipedia:http://en.wikipedia.org/wiki/Deferasirox
RxList:http://www.rxlist.com/cgi/generic/exjade.htm
See more
See less
|
| CASRN | 201530-41-8
|
| prefixIRI | obo2:dinto_DB01609
|
| SMILES | OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O
|
| may interact with | |
| InChI | InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28)
|
| DBBrand | exjade
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |